Carvedilol ER 10 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FJ5EX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,002
Award facts
- Contract value 100% obligated
- $22,001.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $22,001.71 on September 22, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units). This is a firm fixed price delivery order with no set-aside designation, executed under competitive procurement procedures. The contract specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of September 23, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, is a critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs globally. The Defense Logistics Agency's Medical Supply Chain utilizes such vehicles to efficiently fulfill varied pharmaceutical requirements across the defense and veteran healthcare enterprise. Carvedilol, a beta-blocker used in cardiovascular treatment, represents the type of essential generic pharmaceutical commodity routinely procured through DLA's medical supply operations.
Quick answers
Who was awarded contract SPE2DB25FJ5EX?
SPE2DB25FJ5EX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FJ5EX worth?
The government has obligated $22,002 on SPE2DB25FJ5EX.
Is contract SPE2DB25FJ5EX an order under another contract?
Yes. SPE2DB25FJ5EX is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ5EX competed?
The extent of competition for SPE2DB25FJ5EX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award